⌘K

Login Start Free

Home/Filings/4/0001140361-15-001483

4//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4

Accession 0001140361-15-001483

$IRDCIK 0001228627operating

View on SEC.gov Company Profile

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 6:22 PM ET

Size

19.6 KB

Accession

0001140361-15-001483

Insider Transaction Report

Form 4

Period: 2015-01-08

REXAHN PHARMACEUTICALS, INC.RNN

DirectorCFO

Transactions

Exercise/Conversion
Common Stock
2015-01-12$0.80/sh+49,800$39,840→ 554,800 total
Exercise/Conversion
Stock Option (right to purchase)
2015-01-12−49,800→ 182,728 total
Exercise: $0.80Exp: 2015-01-20→ Common Stock (49,800 underlying)
Sale
Common Stock
2015-01-12$0.91/sh−49,800$45,492→ 505,000 total
Exercise/Conversion
Stock Option (right to purchase)
2015-01-09−188,690→ 232,528 total
Exercise: $0.80Exp: 2015-01-20→ Common Stock (188,690 underlying)
Sale
Common Stock
2015-01-09$0.92/sh−188,690$172,708→ 505,000 total
Sale
Common Stock
2015-01-08$0.90/sh−78,782$70,935→ 505,000 total
Exercise/Conversion
Common Stock
2015-01-09$0.80/sh+188,690$150,952→ 693,690 total
Exercise/Conversion
Stock Option (right to purchase)
2015-01-08−78,782→ 421,218 total
Exercise: $0.80Exp: 2015-01-20→ Common Stock (78,782 underlying)
Exercise/Conversion
Common Stock
2015-01-08$0.80/sh+78,782$63,026→ 583,782 total

Footnotes (5)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F2]The price of $0.9004 per share represents a weighted average of sales prices from $0.90 to $0.9088 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F3]The price of $0.9153 per share represents a weighted average of sales prices from $0.90 to $0.945 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F4]The price of $0.9135 per share represents a weighted average of sales prices from $0.90 to $0.9325 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F5]Options vested and became exercisable based on the following schedule: 150,000 on January 20, 2006, 150,000 on January 20, 2007, and 200,000 on January 20, 2008.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001228627

Filing Metadata

Form type: 4
Filed: Jan 11, 7:00 PM ET
Accepted: Jan 12, 6:22 PM ET
Size: 19.6 KB

View on SEC.gov